New Year Bumper Sale @ Rs. 1 X
Ignalis M Tablet is an allopathic medicine The correct dosage of Ignalis M Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Ignalis M Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Ignalis M Tablet safe for pregnant women?
Ignalis M Tablet has little to no side effects in pregnant women.
Is the use of Ignalis M Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Ignalis M Tablet. If you see any side effects, stop taking Ignalis M Tablet immediately and talk to your doctor. Take Ignalis M Tablet again, only after your doctor's advice.
What is the effect of Ignalis M Tablet on the Kidneys?
Ignalis M Tablet is completely safe for kidneys.
What is the effect of Ignalis M Tablet on the Liver?
Ignalis M Tablet does not damage the liver.
What is the effect of Ignalis M Tablet on the Heart?
There are no any side effects of Ignalis M Tablet for the heart.
Ignalis M Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Ignalis M Tablet unless your doctor advises you to do so -
Is this Ignalis M Tablet habit forming or addictive?
Ignalis M Tablet is not addictive in nature.
Interaction between Food and Ignalis M Tablet
Due to a lack of research, nothing can be said about the consequences of taking Ignalis M Tablet together with food.
Interaction between Alcohol and Ignalis M Tablet
Taking alcohol with Ignalis M Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Januvia® (sitagliptin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 274-275
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1143-1144
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826